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A VERY LUCRATIVE LIQUID: THE EMERGING TRADE IN HUMAN MILK AS A 
FORM OF REPRODUCTIVE EXPLOITATION AND VIOLENCE AGAINST 
WOMEN
I. INTRODUCTION
In recent decades, extensive work has been done worldwide to promote breastfeeding (Akre, 
Gribble, & Minchin, 2011). Healthcare professionals routinely emphasise that human milk is 
the gold standard for infant feeding, while research continues to show the benefits of 
breastfeeding to both mother and infant. Demand for human milk has therefore expanded, 
especially in developed settings like the United States (US) and United Kingdom (UK), as 
increasingly diverse families seek perceive the benefits of milk for feeding even where a parent 
is unavailable or unable to produce it  herself (Dutton, 2011). However, markets now exist in 
human milk not just for infant feeding, but also that market milk as a nutritional or fitness 
supplement, an alternative medicine or treatment regime, and a clean eat for those shunning 
dairy and other commercially produced milks (Steele, Foell, Martyn, & Freitag, 2015; Steele, 
Martyn, & Foell, 2015). Recently, technology has offered new ways for those seeking human 
milk to find it easily, with websites, social media platforms and companies offering 
opportunities to buy, share, and sell milk (Geraghty et al., 2013; Keim et al., 2014).
Awareness of milk banking—a provision where a service collects, screens, processes, 
and hands out, usually by prescription, milk that has been donated by women not biologically 
related to the recipient— and the online sharing and sale of human milk, as well as medical 
research using the milk and its components, have brought its value into sharper focus, and 
consequently raised ethical issues. In some jurisdictions, human milk, like blood, is regulated 
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as a body product and thereby only able to be given altruistically, while other jurisdictions 
either are silent on sale, or instead, regulate milk as a food or via private law, allowing it to be 
bought and sold (David, 2011). The legal frameworks around human milk sale are varied. Some 
now argue, though, human milk should have an explicit monetary and economic value, even 
proposing its inclusion in gross national product (Aguayo & Ross, 2002). Others suggest 
women should be paid for its production, both for breastfeeding and expressing milk, as these 
are forms of work, while some engage a more limited proposal of compensation where a 
woman is feeding a child other than her own (Carter & Reyes-Foster, 2016). What is clear is 
that these claims have (re)opened discussion both of human milk as a commodity and 
breastfeeding as a service. While the ethics of breast milk sale continue to be debated, for-
profit entities have moved into the space. Mirroring what happened with human blood, which 
resulted in the World Health Assembly (1975) expressing serious concerns about the impact of 
for-profit enterprises in interfering with health services in developing countries, as well as in 
crowding out altruistic driven blood donations, we are left with questions about the ethics of 
commodifying human milk, and concerns about exploitation and trafficking,
Most recently issues around the emerging market were highlighted when Utah-based 
Ambrosia Labs, sold human milk collected from Cambodian women to be sold in the US, 
drawing international controversy and comment (AFP, 2017; Boseley, 2017; Forster, 2017; 
Wong, 2017). The company, on its now defunct website, claimed to be the first company to 
make breast milk produced overseas commercially available in the US. It stated that it provided 
an income opportunity for women in Cambodia, whose own babies are older than six months 
old. However, the government swiftly suspended the operation, citing concerns about local 
children's nutritional needs and laws on trafficking in body parts (AFP, 2017; Bosel y, 2017; 
Forster, 2017; Wong, 2017).
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The exploitative nature of the business operation was also discussed as it was noted by 
investigative journalists that the women were being paid a mere US$0.64 an ounce, typically 
making a little over US$7 a day pumping as their primary job, while the company was selling 
the milk for US$4 an ounce (Wilson, 2017). Ros Sopheap, the director of NGO Gender and 
Development for Cambodia (GDC), was cited stating that there had been intentional targeting 
of poor women who lack other job options, while others noted substantial issues around the 
market and the failing to address the structural issues that drove these women to sell their milk 
(Wilson, 2017). Indeed, while explicit charges around  “trafficking in persons” and “violence 
against women” were not directly raised by the government, only trafficking in body parts and 
products, UNICEF's Cambodia spokeswoman Iman Morooka highlighted that  "[b]reast milk 
banks should not be operated by exploiting vulnerable and poor Cambodian women for profit 
and commercial purposes”. UNICEF also stated to Reuters that “[b]reast milk could be 
considered as human tissue, the same as blood, and, as such, its commercialization in Cambodia 
should not be supported” (Thomson Reuters Foundation, 2017).
The ethical considerations, and also the issue of regulating the trade worldwide, became 
apparent. While many believe that consent lays at the heart of whether the arrangement is 
exploitative or violent, others were quick to suggest that structural issues mean that all milk 
sale by intermediaries amounts to the wrongful commoditisation of women’s bodies and 
therefore violence against women through reproductive exploitation. Questions arise, 
including: is the commercialisation of milk a form of exploitation of women’s bodies? Does 
human milk sale raise specific issues around trafficking in persons, like we have seen with 
surrogacy, where women are held, their diets dictated, and their freedom limited? Are the 
current ethical and international legal approaches sufficient to address the continuum of 
exploitation that could exist around this new trade?
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Notably, much of the literature to date has focused on the nutritional integrity of the 
milk and the health risks for infant and adult consumers (Geraghty et al., 2013; Keim et al., 
2014; S Steele, Martyn, & Foell, 2015; Sarah Steele, Foell, et al., 2015). Ethical concerns of a 
broader nature, like whether human milk should be commercialised, collected by public entities 
as a collective resource, or altruistically given, have all been tenuously linked to women 
through the figure of consent (see, for example, Hartmann, 2019 for a comprehensive list of 
hazards related to human milk use and exchange). While discussions about ethical concerns in 
relation to the use of women’s bodies exist from feminist or gender justice perspectives (see, 
for example, Dickenson, 2002), the bulk of the debate tends to remain limited to the 
consideration of technical and operational hazards, without being explicit enough in 
recognizing gender-specific issues and potential inadequacies of the current framework to 
address potential forms of exploitation around human milk.
By responding to the Cambodian case as one of trafficking in body parts, an implicit 
assumption was exposed: considerations around human milk allows ethical resolutions that are 
not gender-focused and exist within generic ethical spaces. However, international press 
coverage laid bare the issues around reproductive exploitation and the potential for this industry 
to draw towards behaviours of the past where slaves were exploited to feed other women’s 
infants. We therefore begin by exploring the current issues in the space, detailing both historic 
and contemporary structural injustices experienced by women selling their milk, and exploring 
the ethical and legal issues marked out at present. We then move to explore potential issues for 
the future as the market evolves further, detailing considerations for policy makers and the 
international community. We finish by exploring what steps must be taken to prevent further 
exploitation and potential violence against women and violence against women in this space.
II. CONTEMPORARY ISSUES AROUND HUMAN MILK SALE AND 
EXPLOITATION
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Human milk has most commonly been discussed with relevance to explicit rights for the mother 
and infant to engage in breast feeding. The ethical relevance of human milk lies, principally, 
on the considerable and growing evidence of the central role that breastfeeding plays in the 
health and long-term development of infants (World Health Assembly, 1992, 2018). Human 
milk’s ethical relevance is hence, of course, even greater when placed in the context of the 
inherent dignity and worth of the human person enshrined in the Universal Declaration of 
Human Rights (United Nations, 1948). We note that breastfeeding and the expression of human 
milk cannot be in fairness disassociated from that which should only result from the appropriate 
exercise of women’s reproductive rights (i.e., pregnancy and birth), breastfeeding cannot be 
possibly seen as an isolated bodily function. In the spirit of the brotherhood and sisterhood that 
humans should behave (United Nations, 1948), the moral logical consequence from the 
inseparability of pregnancy, birth, and any form of human milk expression, is that women who 
can express milk in excess of that which is required to feed their own infants, could as well 
help those who cannot produce enough or any. From this perspective, the challenge of making 
this happen is, then, one of collective/social coordination. Such coordination has taken multiple 
forms, including peer-to-peer sharing (a largely community-based, informal practice) and milk 
banking (often a formalised, regulated practice). 
Notably, however, demand for milk has been growing. Increased awareness about 
milk’s beneficial qualities,  preference for using donated human milk over formula (American 
Academy of Pediatrics, 2012), and increasing family diversity, have resulted in considerable 
increases in the demand for human milk (Fein et al., 2008). Indeed, technological and legal 
developments have meant that a nursing mother may not exist within a family structure. For 
example, the mother may be deceased, having passed away during or after birth or even prior 
to conception, as egg freezing and in-vitro fertilisation making posthumous conception now 
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possible, yet controversial (Collins, 2005; Simana, 2018). Further, a mother may never have 
been part of the intended family unit at all, with some gay, queer, transgender, non-binary, and 
others using surrogates who do not then form part of the family and may have no further 
involvement in the infant’s feeding after delivery. Additionally, the rise of risk reducing 
surgeries and breast cancer detection in younger women, alongside elective surgical procedures 
like breast implants that may impact on ability to breastfeed, have increased the pool of mothers 
unable to feed themselves but who may still prefer human milk, alongside mothers who for 
milk supply or other reasons may be unwilling or unable to feed the infant themselves (Roberts, 
Ampt, Algert, Sywak, & Chen, 2015; Williams, 2018).
Meanwhile, adult consumptionintake has increased as consumers see uses in sports 
nutrition, alternative medicine, and “clean” eating (Forgues, Mazanov, & Smith, 2017; Steele, 
Foell, et al., 2015). With such growing demand, as well as because of limited supply, scarcity 
has spikedthere has been insufficient milk available for all of those seeking it for infant-feeding, 
especially in the milk-banking provision, where limitations on who can access the banks and 
for what purpose  have been implemented (DeMarchis, Israel-Ballard, Mansen, & Engmann, 
2017).  Alongside informal sharing networks (Akre et al., 2011; Fein et al., 2008; O’Sullivan, 
Geraghty, & Rasmussen, 2016), companies, and online commercialisation spaces have 
emerged. Other options like Prolacta are expensive and may be out of reach for many 
caregivers, and therefore private mechanisms for sale or exchange may be preferred (Pollack, 
2015). None of tThese private mechanisms of dealing with scarcity are not new, however; in 
many respects, with human milk banks havinge existed since the early 1900s, and wet-nursing 
has, both in paid and unpaid forms, existinged for millennia (Mayerhofer, 1954; Moro, 2018).
However, new technologies and improved logistics have changed previous practices 
and created the possibility for new ones. Among these, perhaps the most important ones have 
been online platforms that facilitate trade, devices and accessories that facilitate the expression, 
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adequate storage, and transportation of human milk across vast distances, and developments in 
biomedical research that require cells or proteins from human milk (O’Sullivan et al., 2016). 
Indeed, these very developments made it possible for a US-based company to initiate collection 
of milk from mothers in poverty in Cambodia, ship it internationally, and distribute it to buyers 
in the US. 
Such a capacity to move milk, locally, nationally and internationally to meet growing 
demand raises ethical, legal and social questions, but notably, while these considerations are 
beginning to be discussed, commercial interests are already crowding out altruist interest in the 
appropriation of available supplies. For example, Miracle et al.  (2011) show that the 
International Breastmilk Project (IBMP), a not-for-profit created to ship human milk from the 
US to developing countries in need, had by 2011 sent donations of about 260,000 ounces of 
human milk; these donations represented only about 25 percent of the human milk donations 
received by IBMP. The remaining milk—all 75 percent of it—was sold by IBMP to Prolacta, 
a private company, which sells at a considerable profit, human milk products for neonatal care. 
Further to this, while corporations have the proprietary ability via their technology to greatly 
reduce the risks potentially posed by milk, this technology is not widely available at a low cost 
to most caregivers, having been subject to intellectual property protections and reduced the 
potential for research into scalable solutions. With increased adult consumption, such 
reallocation may mean that there is a shift from meeting the demand from hospitalized neonates, 
one of the most vulnerable populations in need (Kim & Unger, 2010), to the adult market.
Another consideration met with some interest has been the safety of the milk for 
consumption both by infants and those adults who are immune compromised in light of an 
emerging pricing structure that sells the milk by volume, and thereby incentivises “watering-
down”. Studies have found, for example, the presence of bovine DNA in samples acquired 
through online channels that were supposed to exclusively contain human milk (Keim et al., 
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2015). Bacterial, viral and contaminant risks have also been highlighted (Keim et al., 2014; 
Sarah Steele, Martyn, et al., 2015). Consequently, government and professional bodies have 
recommended against acquiring milk online. For example, United States Food and Drug 
Administration guidelines recommend against the use of human milk obtained directly from 
individuals or through online means (US Food and Drug Administration, 2019). This is 
recommended as well by the American Academy of Pediatrics (Committee on Nutrition, 
Section on Breastfeeding, 2017).
However, the Cambodia case internationalised existing questions about the exploitation 
of minority women’s bodies which were already emerging in the US, where commercialisation 
had progressed rapidly in the digital age. Indeed, local protests against biomedical companies 
in Detroit in the US resulted in grass-roots campaigns against a company that evoked imagery 
of slavery and using African-American women like dairy cows (Harrison, 2019). In the US, 
where commercialisation of human milk and the operation of Ambrosia Labs took place, it is 
notable that wet-nursing historically marked out forms of racialized reproductive labour, which 
served to divert breast milk from marginalized babies to more privileged ones. Estimates 
suggest that roughly twenty per cent of slave-owning families in the US utilized enslaved 
women as wet nurses for their white infants (Blum, 1999). Newspapers from the eighteenth 
and early nineteenth centuries featured advertisements for black wet nurses, either to employ 
or to purchase as slaves (Spruill, 1988). Such connections were drawn directly to commercial 
practices of milk banking in the US, and around biomedical companies use of minority women, 
particularly African-American women, for commercial gain and for the use of the socio-
economically privileged, many of whom are white (Harrison, 2019). Indeed, in exploring why 
Ambrosia Labs had used Cambodian women, it was noted how difficult the American market 
in milk had become in light of recent protests and boycotts, and thereby how international 
markets offered a more perfect solution (Wilson, 2017).
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Given the possibility that for-profit companies have to considerably increase the 
perceived value of their products through investments in research and development, capital, 
and marketing (Dutton, 2011; Ganapathy, Hay, & Kim, 2012; 2017), the relative competitive 
and comparative advantages they can build and acquire through these can create perverse 
incentives to export human milk to locations where the price and therefore profits might be 
bigger, as well as to import human milk from locations where the costs is much lower, and 
even perhaps its availability bigger. In practical terms, this situation could result in the draining 
of human milk from poorer countries into richer ones, the exploitation of women and girls in 
developing settings, and even potentially the recruitment and harbouring of women for the 
purpose of milk “farming” like has been seen around surrogacy and “baby farming”. We 
explore this potential in the sections that follow.
III. FUTURE ISSUES AROUND HUMAN MILK SALE
At present, much of the human milk industry rests on either the sale of milk by women who 
have produced an excess, or on women in socio-economic deprivation who are engaged to 
pump in exchange for financial or other incentives. Where pumping milk is done explicitly for 
sale of that milk, we have seen already that there are demands for dietary shifts by the women 
expressing the milk (no caffeine or alcohol, vegetarian/vegan/gluten free/paleo/clean- eating 
etc all feature in advertisements on onlythebreast.com, for example), and also behavioural 
changes around exercise, residency, and number of times pumping per day (Keim et al., 2014). 
Where excess milk is produced, it is often shared, as the conditions of expressing it and storing 
it often do not meet commercial demands (American Academy of Pediatrics, 2012). It is 
therefore likely that the commercial market will move more towards engaging women for the 
purposes of pumping, rather than the purchase of pre-existing excess supplies.
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Links to surrogacy exploitation becomes apparent in this new configuration where 
lifestyle and diet become part of the contractual terms of sale. Surrogacy arrangements reported 
in research have observed women being kept in hotels or other residences where their activities 
and in-takes can be monitored to comply with the demands of intended parents (Duong, 2012), 
although framing is often placed on these provisions as a benefit to the surrogate who often 
comes from poverty and therefore is provided with food and care she otherwise would not 
receive. Past cases have involved women reporting control being placed over their movement, 
their sleeping patterns and what they are given to eat and drink. The international press 
therefore picked up on the need to urgently consider surrogacy internationally, and to revise 
laws.  Notably, in 2011, the European Parliament highlighted how:
women and children are subject to the same forms of exploitation and both 
can be regarded as commodities on the international reproductive market, 
and that these new reproductive arrangements, such as surrogacy, augment 
the trafficking of women and children and illegal adoption across national 
borders (European Parliament, 2011, para. 21).
Again, in 2015, European Parliament condemned:
the practice of surrogacy, which undermines the human dignity of the 
woman since her body and its reproductive functions are used as a 
commodity; considers that the practice of gestational surrogacy which 
involves reproductive exploitation and use of the human body for financial 
or other gain, in particular in the case of vulnerable women in developing 
countries, shall be prohibited and treated as a matter of urgency in human 
rights instruments (European Parliament, 2014, para. 115).
Previously, a report from the European Parliament (2009, p. 25) noted that:
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Respecting, promoting sexual and reproductive health, and protecting and 
fulfilling reproductive rights is a necessary condition to achieve gender 
equality and the empowerment of women to enable them to enjoy all their 
human rights and fundamental freedoms, and to prevent and mitigate 
violence against women.
It is not unforeseeable that the more extreme cases of human milk commercialisation may result 
in similar exploitation of women and control over them in order to deliver on demands from 
buyers about diet and exposure to chemicals and other carcinogens by those producing the 
milk.
Issues arise around the adequacy of existing international agreements and national laws 
in covering this possible form of reproductive exploitation. Article 3, paragraph (a) of the 
Protocol to Prevent, Suppress and Punish Trafficking in Persons defines “Trafficking in 
Persons” as:
the recruitment, transportation, transfer, harbouring or receipt of persons, by 
means of the threat or use of force or other forms of coercion, of abduction, 
of fraud, of deception, of the abuse of power or of a position of vulnerability 
or of the giving or receiving of payments or benefits to achieve the consent 
of a person having control over another person, for the purpose of 
exploitation. Exploitation shall include, at a minimum, the exploitation of 
the prostitution of others or other forms of sexual exploitation, forced labour 
or services, slavery or practices similar to slavery, servitude or the removal 
of organs. 
What is unclear here is whether forced milk sale should rightly be considered forced labour or 
the removal of organs, or whether the inherently gendered nature of this exploitation is 
deserving of the addition of a further category of reproductive exploitation. Cambodia in its 
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statements clearly devised that it was able to stretch its laws on trafficking in organs to include 
products from human organs including human milk, which marks a stark departure from the 
law in other jurisdictions in which human milk is often classified differently due to its 
renewable nature (although such a clarification ignores the energy, nutrients and labour of the 
producer of the milk—the mother). While Cambodia investigated the case, suspending the 
company from operating in the country, the language government officials used in the 
international press drew direct links to the organ trade and surrogacy, both of which have 
attracted interest internationally.
However, law reform has not yet been considered internationally, and the human milk 
and reproductive exploitation remain under-discussed in the anti-trafficking and violence 
against women context. For example, the WHO’s Principles on the donation and management 
of blood, blood components and other medical products of human origin: Report by the 
Secretariat, (2017) classifies breast milk among a group of medical products of human origin. 
These “biological materials that are derived wholly or in part from the human body and are 
intended for clinical application” also include blood, plasma, ova, sperm and other types of 
tissue. Most of those materials come with guidance around how they should be selected, 
screened and tested, but notably have been interpreted not as organs for the purposes of 
international laws on trafficking, by-and-large. 
There is also a failing to address the potential for overlapping forms of exploitation, 
where women are exploited as surrogates and then forced to provide milk not just for the infant 
they birthed, but also potentially for others. Indeed, we have seen cases of women deprived of 
their liberty for the purposes of surrogacy and decoupling this from their production of milk 
for infant feeding would be problematic. It is further to be considered that women may be 
forcibly engaged as surrogates in the most egregious cases, where an overlap with sex 
trafficking may emerge through the rape of the women (Abdullah, 2019). It is therefore critical 
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to consider reproductive trafficking alongside other forms of violence against women, as but 
one expression of the various human rights violations that women experience by virtue of their 
gender.
By placing the most extreme cases of exploitation for human milk as a form of labour 
trafficking, alternatively, the issue becomes the overlooking of the implicitly gendered nature 
of the violence which can only be directed at women who are lactating. It ignores that many 
women who are engaged in developing settings have few financial options, low levels of 
literacy, and by virtue of being new mothers often lack options to gain other employment due 
to discriminatory, patriarchal systems. Knowledge about the health risks to both the mother 
and their infant of her pumping for profit are also problematic, and many investigations by the 
press have raised questions about levels of knowledge and whether consent is real (Forster, 
2017; Wilson, 2017; Wong, 2017). It is also worth noting that such obfuscation of the gender-
based aspects of the trade also overlooks that demand for human milk also arises from 
inadequacies in healthcare for mothers (e.g. a lack of availability or insurance coverage for 
lactation consultation), and also by a lack of leave for new mothers and support for 
breastfeeding in workplaces in places like the US. Indeed, by moving discussion outside of a 
gendered lens, and by covering the most extreme cases of human milk exploitation under a 
framework of labour trafficking, the structural causes of reproductive exploitation may be 
concealed.
However, moving beyond the most extreme cases of deprivation of liberty as an evident 
and concerning form of violence against women, it is worth noting that milk production for 
commercial sale even with consent inherently raises gendered exploitation as an issue. To meet 
unmet demand for human milk, it is notable that this can only be satisfied by women and their 
bodies given they are the only humans who produce human milk. Therefore, in principle, there 
is an unequal burden by design on women that is likely to have a physical and emotional toll 
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on them. The physical demands these impose exclusively on women which not only consume 
the energy that characterizes labour, but that actually transforms their physical and emotional 
states differently than any other job  (Hartmann, 2019). The transaction nature of a commercial 
arrangement equates payment as remunerating women for these inconveniences and the energy 
spent — a right also enshrined in the Universal Declaration of Human Rights, Article 23 
(United Nations, 1948). However, such compensation cannot offset many of the physical and 
emotional burdens being placed directly on women’s bodies, and only on women’s bodies. 
It is notable that the commercial human milk sale is inordinately enticing for women 
who lack other remunerable options, like the women who were identified in the Cambodian 
case, or even for women in US who, while employed, have been shown to experience steep 
declines in their annual income due to breastfeeding constraints faced in the labour markets 
(Rippeyoung & Noonan, 2012). A simple analysis of the economics of human milk can help 
illustrate why this is the case. In the US, members of a form of human milk bank termed Mother 
Milk Cooperatives, can receive compensation for human milk “donations” in the order of 
US$500-800 (Clinton Global Initiative, 2019). This represents between US$17-27 a day, levels 
of compensation that are between 3 to 5 times higher than those of about 46 percent or about 
3.5 billion people who rely on USD 5.5 a day to survive (World Bank, 2019). Indeed, the 
income that “donating” human milk can generate has been discussed as a taxable source of 
income (Zelenak, 2017). This is not surprising given that several studies  Bartick et al., 2017; 
Bartick & Reinhold, 2010) have shown not only that the opportunity costs of breastfeeding not 
being the exclusive source of nutrition during the first 6 months of infant life are in the order 
of US$13-14 billion. Another study (Smith, 2013), quantifies the annual value of human milk 
production at exceeding US$3.6 billion in Australia, under US$1 billion in Norway, and a 
massive US$45 billion in the United States. This study estimates, however, that annually about 
US$63 billion in the US, about US$600 million in Norway, and US$4 billion in Australia are 
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lost because women’s right to lactate are not protected, and because competing milk sources 
(e.g., infant formula) crows out human milk production. Aguayo & Ross (2002), estimated that 
in Francophone West Africa, children under 35.9 months old consume more than 1.1 billion 
litres of human milk in a year; this, the authors estimate, could have an opportunity cost of 
about US$2 billion, or about US$412 per infant (US$1.13 per day), if the same milk were to 
be sourced from breastmilk substitutes.
Another way to understand the economics of human milk and the perverse incentives 
that commodifying it can create is by looking at the potential volume of milk that a woman can 
generate and the income she could collect for this volume. The studies mentioned above 
assume an estimate milk production per woman at about 850 mL or about 30 ounces (this is 
for women who are exclusively breastfeeding) (Smith, 2013). US human milk banks and 
internet-based trading sites sell an ounce of milk at around US$3 or more, which means that a 
lactating woman could sell her daily production for about US$90 a day. Compensation for wet-
nursing can range between US$50-200 per day in the US and in China (Smith, 2013). However, 
the Cambodian case demonstrated that women receive much lower compensation when they 
are in developing settings, and also where other charges around testing, dietary 
supplementation, and food or accommodation specifications must be met. Indeed, this case 
highlighted how much of the profit does not flow on to women, but to intermediaries.
There are also questions about whether the conditions are adequate and the 
compensation fair in light of what the milk is sold for in the end market. For example, while as 
stated above, a woman who sells her entire expression of milk in a day could theoretically—
e.g. in the very best market conditions and in developed settings— earn about US$90, 
intermediaries selling milk in the US can earn for the same volume about US$1,000. Private 
producers of even more specialized human milk-based products like “fortifiers” can earn up to 
about US$5,300 (Fentiman, 2009; Smith, 2013). In yearly terms, this differences add up to 
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astonishing differences: even if a woman manages to maintain her milk production at the 
estimated 850 mL for every single day in a year, she could earn a maximum total of US$32,850, 
while private companies can earn for the same volume of human milk between US$367,025 
and US$1,939,000. Many have argued that these disparities in income evidence serious on-
going ethical issues, and also clearly indicate the exploitation of women with unfair and 
unequal levels of compensation. The transactions involving unequally vulnerable parties and 
considerable market asymmetries which must be addressed.
It is also worth noting non-financial impacts of the growing number of intermediaries. 
Intermediaries between donors, mothers, and infants remove the possibility of such bonds and 
might ignore as well cultural sensitivities that if transgressed may result in negative 
consequences like reduced donation, refusal to accept donated milk, and others (Gürol, Özkan, 
& Çelebioğlu, 2014). Emphasis on efficiency, effectiveness, and quality, as in the case of the 
commercial manufacturing of goods and the provision of services, contributes to further 
commodify women and the fruits of their body and labour. The emphasis on productivity is 
made clear by a patent granted on a human milk pumping device:
U.S. Pat. No. 4,772,262, which is hereby incorporated by reference in its 
entirety, is directed to technology for milk removal. As disclosed in that 
patent, milk yields increase due to the sensory stimulus provided by the 
patented breast pump equipment. When milk yield increases, the 
formulation of milk including many of the valuable immunoglobulins also 
increase along with living cells, such as macrophages and lymphocytes. 
Lipids also increase and the mother's body responds to the stimulus by 
producing higher levels of prolactin that will trigger continuing milk Supply 
and the secretion of additional nutrients into her milk. (United States Patent 
and Trademark Office, 2010, pp. 7–8)
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Furthermore, it would be difficult to deny that the advertisement of human milk as a product 
for sale that is presented professionally packaged, with colourful labels, and memorable names, 
all while removed from images of the women who expressed it, does not contribute 
significantly in future commodifying, if no women, at least the biological expression of their 
bodies. Likewise, by focusing marketing oriented messaging used in their promotion on the 
“value added” characteristics that separate one company’s product from that of another—being 
the most likely those related to safety and quality—it is likely as well that with time, the deeply 
human and moving image of a women breastfeeding her child and the maternal bond they 
represent, will be substituted by one of fear and concern about the quality of the “product”.
Indeed, by allowing the commercialization of human milk, the transactional structure 
of breastfeeding and expressed milk sharing changes. While breastfeeding is the preferred and 
recommended choice for the wellbeing of mothers and infants, this is at odds with the 
“wellbeing” of the private enterprise which profits from the cases where there is no 
breastfeeding. It is also of the interest of these enterprises that no altruistic organizations 
crowd-in the spaces on which they can profit. This creates considerable incentives for the for-
profit enterprises to exercise all their skills and dedicate important resources to absorb as much 
as the demand for human milk as it is possible, which means displacing breastfeeding 
(Hartmann, 2019). Among the problematic things these enterprises could do that affect women 
are: (i) taking advantage of good will of potential donors through questionable emotional and 
financial inducements; (ii) influencing regulators to create barriers of entry that result in market 
consolidation and therefore less competition; (iii) offering suboptimal conditions that could 
result on emotional and physical harm to donors who because of their disadvantageous position 
might be improperly induced to accept such condition—this could be worsen if women in even 
direr conditions, for example from other countries, are available (Hartmann, 2019; Pirnay et 
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al., 2010); (iv) this and other actions can end up discouraging and deteriorating altruistic 
attitudes that can lead to donation and facilitation (Pirnay et al., 2010).
While human milk has an extremely high inherent value, the expression of this value 
in monetary terms, as well as the allocation of this value among those involved, in particular 
women who play the most relevant role, is not a “naturally occurring” event. It is regulation or 
the lack thereof, what translates value into money and what determines the allocation of such 
value among those who participate as producers, intermediaries, and consumers (Dickenson, 
2002). Even those who believe in “free markets” would be able to appreciate that the mix of 
historical and structural abuse, violence, and exploitation against women, incomplete 
information (e.g., not all participants are well informed nor able to engage in a consensual and 
free market transaction), and asymmetric power and information (e.g., for-profit enterprises 
have the advantage in an unregulated market), make consent problematic, and law reform 
necessary. 
IV. CONCLUSION
The sale of human milk marks a new market where the exploitation of women’s bodies 
becomes possible through the commodification of a purely female produced substance. We 
have argued that this is therefore an issue of gender justice and equality that must not be 
structurally removed from exploring violence against women by regarding milk production as 
labour and human milk as a product that can be bought and sold, especially through 
intermediaries. Entrenched and evident structural injustices mean that this and other gender 
related issues should remain in gender-specific ethical and legal spaces, making explicit 
consideration of trafficking in women and girls for reproductive exploitation critical to consider, 
while addressing alongside it the commercialisation of body products alongside organ 
trafficking.
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Allowing the sale of milk would reflect a commodifying and commercialist approach 
to public health, holding women and girls responsible for improving health outcomes in their 
communities that are, in reality, tied to systemic and structural racism, classism, and 
inequalities more broadly. This approach privatises infant nutrition at the expense of true 
reproductive justice, which demands broad social support for women’s human rights (Ross, 
2017). With developments in biotechnology facilitating the commodification of reproduction, 
including the production of human milk and its use (not just for feeding but also biomedical 
applications), we should note that a new door that has been opened for yet further disregard 
and degradation of women and girls’ humanity, as well as their physical and emotional 
wellbeing. Respect for human rights and equal justice – particularly for the most vulnerable 
globally– must be first and foremost in consideration and policy development.
Meanwhile our research on human milk sale must move beyond discussions of public 
health harms and peer-to-peer exchange, to explore the broader commercialisation of human 
milk at an international level. Biomedical developments and also technological capacities for 
shipping and processing milk across vast distances fundamentally shift existing discussions of 
wet nursing and milk donation which have assumed to be between women or between women 
and children, rather than to involve legal entities (e.g. companies). Such a discussion must 
occur within a space that carefully respects breastfeeding and long-held customary practices 
around infant feeding in diverse cultures, but that addresses the exploitative elements of 
commercialised trade.
Ultimately, it seems preferable not only to prohibit any kind of financial gains related 
to human milk by legal entities, but to also explore and enact regulations that address the 
present and forthcoming issues we detail in this paper. It is critical that governments around 
the world address the emerging exploitation of women within their countries and across borders, 
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while affording women and girls substantial support and protections around maternity and 
breastfeeding.
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